Atika Capital Management »

Crispr Therapeutics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 48k 68.16
2020-09-30 $5.8M 70k 83.57
2018-09-30 $888k 20k 44.38
2018-06-30 $4.2M 72k 58.73